← All indications
Essential Tremor
A relatively common disorder characterized by a fairly specific pattern of tremors which are most prominent in the upper extremities and neck, inducing titubations of the head. The tremor is usually mild, but when severe may be disabling. An autosomal dominant pattern of inheritance may occur in some families (i.e., familial tremor). (Mov Disord 1988;13(1):5-10)
Drugs by status
Phase 4 trials (5)
Phase 2 trials (24)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (7)
Organization Involved with Phase 3 Indications (6)
Organization Involved with Phase 2 Indications (16)
- Jazz Pharmaceuticals
- Cavion LLC
- Merz
- Sage Therapeutics
- Arvelle
- Sonexa Therapeutics, Inc.
- Tilray
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institute on Deafness and Other Communication Disorders (NIDCD)
- Syracuse University
- University of California, San Diego
- Taro Pharmaceuticals
- Quest Research Institute
- University of Western Ontario
- Cadent Therapeutics
- international essential tremor foundation
Organization Involved with Other Experimental Indications (3)